Related Experiment Video
Updated: Dec 15, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Refractory Hypotension During General Anesthesia Despite Withholding Telmisartan
Takayuki Hojo1, Makiko Shibuya1, Yukifumi Kimura1
1Department of Dental Anesthesiology, Faculty of Dental Medicine and Graduate School of Dental Medicine, Hokkaido University, Sapporo, Japan.
Withholding angiotensin receptor blockers (ARBs) like telmisartan for 24 hours may not prevent severe hypotension during anesthesia. A longer washout period is recommended for patients on telmisartan.
Area of Science:
- Anesthesiology
- Pharmacology
- Cardiology
Background:
- Angiotensin receptor blockers (ARBs) are widely prescribed for hypertension.
- ARBs, like ACE inhibitors, can cause refractory hypotension during general anesthesia.
- Current guidelines recommend withholding ARBs for 24 hours before anesthesia.
Observation:
- A case of refractory hypotension occurred despite a 24-hour telmisartan washout before general anesthesia.
- The patient experienced less severe hypotension after a 5-day telmisartan washout in a subsequent anesthetic.
- Telmisartan has the longest half-life (24 hours) among currently used ARBs.
Findings:
- A 24-hour washout period may be insufficient to prevent severe intraoperative hypotension in patients taking telmisartan.
- Refractory hypotension necessitates potent vasopressors, increasing anesthetic risk.
- A washout period exceeding 24 hours is likely required for telmisartan.
Implications:
- Anesthesiologists should consider extended washout periods for telmisartan.
- Patient management may require tailored pre-anesthetic medication withdrawal protocols.
- This highlights the importance of understanding drug pharmacokinetics in perioperative care.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Potassium-Sparing Diuretics

